Peripherally inserted central catheters (PICCs) are frequently used to obtain central venous access for patients in acute care, home care and skilled nursing care. PICCs are a reliable alternative ...

The CVC market is projected to grow from USD 2,861.0 million in 2024 to USD 5,436.8 million by 2034 at a CAGR of 6.6%.

The following is a summary of “Central-venous-catheter-related bloodstream infections in adult patients with sickle cell disease: a retrospective, two-centre study,” published in the February 2025 ...

Central venous catheter-related blood stream infection (CRBSI) is a major cause of morbidity and mortality in patients with end-stage renal disease treated with chronic hemodialysis. Risk factors ...

Use of high-dose (46.7%) sodium citrate locks for central venous catheters (CVCs) being used for maintenance hemodialysis provides no advantage over 5% heparin locks in reducing infections or ...

Many states, including Texas and Oklahoma, do not allow execution witnesses to see the insertion of IVs or central venous ...

“As the market leader in both Central Venous Catheters (CVCs) 1 and Arterials 2, we are pleased to offer Vizient provider-customers one of the broadest portfolios of vascular access products ...

Central Venous Catheters All catheters consists of high flexible thin-walled polyurethane which ensures very high flow rates. It is anti-thrombogen and biocompatible. At body temperature it gets ...

Effective January 1, 2025, the agreement grants Vizient’s members access to Teleflex’s Central Venous Access Catheters and Arterial Catheters under pre-negotiated terms, enhancing cost ...

A mural thrombus that significantly restricts blood flow around the catheter may cause symptoms such as swelling near and distal to the point of occlusion, peripheral collateral venous distention ...